Stock screenerAll disclosures →
EDGAR →
HRTX
Conviction 26HealthcareScan · Fri, Oct 9, 2026Heron Therapeutics, Inc. /De/ (HRTX) closed at $0.4061 (+13.37%) on Oct 9, 2026. Price is above its 50-day and below its 200-day moving average. RSI(14) 62, RS Rating 9, -72.9% from its 52-week high, -67.9% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.
HRTX$0.4061+13.37%
ResistanceSupportVol 14Vol MA14 2.62M
Jul 14Jul 30Aug 18Sep 3Sep 23Oct 9
Price0.4061
Change+13.37%
Gap+1.81%
Rel volume1.19×
Avg volume2.67M
Avg $ vol864.37K
SMA 200.3240
SMA 500.3457
SMA 2000.7750
Price vs 50+16.87%
Price vs 200-47.87%
MA stackmixed
50/200 cross—
Supertrendup · 0.2786
RSI (14)62
MACD hist0.01
MACD cross—
Stoch %K / %D96 / 83
ADX (14)25
+DI / −DI26 / 13
RSI divergence—
MACD divergence—
ATR %8.81%
ADR %9.62%
52w high1.49
52w low0.2700
From 52w high-72.89%
Above 52w low+49.63%
New 52w highNo
SqueezeOff
Bollinger width42.40%
%B1.08
Donchian pos95.97%
Donchian high0.4100
Donchian low0.2610
AVWAP (52w high)0.6688
vs AVWAP high-39.59%
AVWAP (52w low)0.3260
vs AVWAP low+23.91%
OBV trendFlat
Chaikin MF (20)-0.02
Today vs 20d1.19×
Avg vol (14d)2.59M
Avg vol (20d)2.67M
Avg $ vol (20d)864.37K
Market cap76.7M
RS Rating9 / 99
RS 3m (vs SPY)-7.01%
RS 6m (vs SPY)-67.22%
RS line new highNo
Trend template2/8
Technical rank42.7
1 week+16.23%
1 month+25.35%
3 months-3.09%
6 months-52.64%
1 year-70.07%
YTD-67.94%
P/E-3.80
P/B11.10
P/S0.50
P/FCF-2.75
EPS-0.1200
Div yield—
ROE-292.34%
ROA-8.01%
Debt/Eq—
Current2.49
EV/EBITDA-249.91
Gross margin73.31%
Net margin-13.04%
Rev growth7.36%
EPS growth-48.71%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value55.98M
Revenue37.67M
Net income-5.49M
Gross profit26.09M
Free cash flow-27.91M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out189.28M
Employees128
ListedThu, Aug 27, 1987
Free float136.31M
Float %72.3%
Short interest44.86M
Days to cover18.5d
Short volume63.0%
Squeeze score83 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction26 / 100
Pattern quality—
Tech rank42.7 / 100
Group rank—
Status laneNo active setup
Setup direction—
Pattern family
Resistance0.3800
Support0.2705
Days since event—
Candle confirm—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in HRTX
No recent disclosed trades by Congress in HRTX. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in HRTX
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Hensley Mark Earl Chief Operating Officer · Common Stock · 2026-08-06 | Exercise | 31.25K | — | 2026-08-06 | 2026-08-10 |
Hensley Mark Earl Chief Operating Officer · Common Stock · 2026-08-06 | Tax | 8.89K | $4K | 2026-08-06 | 2026-08-10 |
Hensley Mark Earl Chief Operating Officer · Restricted Stock Units · 2026-08-06 | Exercise | 31.25K | — | 2026-08-06 | 2026-08-10 |
Forbes William P EVP, Chief Development Officer · Common Stock · 2026-06-06 | Exercise | 12.5K | — | 2026-06-06 | 2026-06-08 |
Forbes William P EVP, Chief Development Officer · Restricted Stock Units · 2026-06-06 | Exercise | 12.5K | $0 | 2026-06-06 | 2026-06-08 |
Hensley Mark Earl Chief Operating Officer · Common Stock · 2026-05-06 | Exercise | 125K | — | 2026-05-06 | 2026-05-07 |
Hensley Mark Earl Chief Operating Officer · Restricted Stock Units · 2026-05-06 | Exercise | 125K | $0 | 2026-05-06 | 2026-05-07 |
Hensley Mark Earl Chief Operating Officer · Restricted Stock Units · 2026-04-30 | Exercise | 11.77K | $0 | 2026-04-30 | 2026-05-04 |
Collard Craig A Chief Executive Officer · Common Stock · 2026-04-30 | Exercise | 34.79K | — | 2026-04-30 | 2026-05-04 |
Duarte Ira EVP, Chief Financial Officer · Restricted Stock Units · 2026-04-30 | Exercise | 11.69K | $0 | 2026-04-30 | 2026-05-04 |
SEC filings
EDGAR filings in HRTX · 7 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.